Korsa Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $21.5M

  • Investors
  • 1

Korsa Therapeutics General Information

Description

Developer of a therapeutic platform designed to generate a novel class of therapeutic antibodies. The company's platform allows for monoclonal antibodies to enter inside the cell and bind intracellular targets, directly expanding the druggable space and unleashing the power of monoclonal antibodies on previously undruggable intracellular targets, enabling users to get an advanced platform to generate therapeutic antibodies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • San Diego, CA 92037
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • San Diego, CA 92037
  • United States

Korsa Therapeutics Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Korsa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 30-Sep-2024 $21.5M Completed Startup
1. Accelerator/Incubator 03-Apr-2023 Completed Startup
To view Korsa Therapeutics’s complete valuation and funding history, request access »

Korsa Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Korsa Therapeutics’s complete cap table history, request access »

Korsa Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avalon Bioventures Venture Capital Minority
To view Korsa Therapeutics’s complete investors history, request access »

Korsa Therapeutics FAQs

  • When was Korsa Therapeutics founded?

    Korsa Therapeutics was founded in 2023.

  • Where is Korsa Therapeutics headquartered?

    Korsa Therapeutics is headquartered in San Diego, CA.

  • What industry is Korsa Therapeutics in?

    Korsa Therapeutics’s primary industry is Biotechnology.

  • Is Korsa Therapeutics a private or public company?

    Korsa Therapeutics is a Private company.

  • What is the current valuation of Korsa Therapeutics?

    The current valuation of Korsa Therapeutics is .

  • What is Korsa Therapeutics’s current revenue?

    The current revenue for Korsa Therapeutics is .

  • How much funding has Korsa Therapeutics raised over time?

    Korsa Therapeutics has raised $21.5M.

  • Who are Korsa Therapeutics’s investors?

    Avalon Bioventures has invested in Korsa Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process